Human iPSC-derived cerebral organoids model features of Leigh syndrome and reveal abnormal corticogenesis

Leigh syndrome (LS) is a rare, inherited neurometabolic disorder that presents with bilateral brain lesions caused by defects in the mitochondrial respiratory chain and associated nuclear-encoded proteins. We generated human induced pluripotent stem cells (iPSCs) from three LS patient-derived fibrob...

Full description

Saved in:
Bibliographic Details
Published inDevelopment (Cambridge) Vol. 149; no. 20
Main Authors Romero-Morales, Alejandra I, Robertson, Gabriella L, Rastogi, Anuj, Rasmussen, Megan L, Temuri, Hoor, McElroy, Gregory Scott, Chakrabarty, Ram Prosad, Hsu, Lawrence, Almonacid, Paula M, Millis, Bryan A, Chandel, Navdeep S, Cartailler, Jean-Philippe, Gama, Vivian
Format Journal Article
LanguageEnglish
Published England The Company of Biologists Ltd 15.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Leigh syndrome (LS) is a rare, inherited neurometabolic disorder that presents with bilateral brain lesions caused by defects in the mitochondrial respiratory chain and associated nuclear-encoded proteins. We generated human induced pluripotent stem cells (iPSCs) from three LS patient-derived fibroblast lines. Using whole-exome and mitochondrial sequencing, we identified unreported mutations in pyruvate dehydrogenase (GM0372, PDH; GM13411, MT-ATP6/PDH) and dihydrolipoyl dehydrogenase (GM01503, DLD). These LS patient-derived iPSC lines were viable and capable of differentiating into progenitor populations, but we identified several abnormalities in three-dimensional differentiation models of brain development. LS patient-derived cerebral organoids showed defects in neural epithelial bud generation, size and cortical architecture at 100 days. The double mutant MT-ATP6/PDH line produced organoid neural precursor cells with abnormal mitochondrial morphology, characterized by fragmentation and disorganization, and showed an increased generation of astrocytes. These studies aim to provide a comprehensive phenotypic characterization of available patient-derived cell lines that can be used to study Leigh syndrome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Handling Editor: James Briscoe
ISSN:0950-1991
1477-9129
DOI:10.1242/dev.199914